Cargando…

Aneuploidy in neuroblastoma tumors is not associated with inactivating point mutations in the STAG2 gene

BACKGROUND: Chromosomal instability is a hallmark of human cancer caused by errors in mitotic control and chromosome segregation. STAG2 encodes a subunit of the cohesion complex that participates in mitotic chromatid separation and was recently found to show low expression and inactivating mutations...

Descripción completa

Detalles Bibliográficos
Autores principales:	Djos, Anna, Fransson, Susanne, Kogner, Per, Martinsson, Tommy
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3853135/ https://www.ncbi.nlm.nih.gov/pubmed/24088605 http://dx.doi.org/10.1186/1471-2350-14-102

Ejemplares similares

Low Frequency ALK Hotspots Mutations In Neuroblastoma Tumours Detected By Ultra-deep Sequencing: Implications For ALK Inhibitor Treatment
por: Javanmardi, Niloufar, et al.
Publicado: (2019)

Multifocal Neuroblastoma and Central Hypoventilation in An Infant with Germline ALK F1174I Mutation
por: Djos, Anna, et al.
Publicado: (2022)

The RASSF gene family members RASSF5, RASSF6 and RASSF7 show frequent DNA methylation in neuroblastoma
por: Djos, Anna, et al.
Publicado: (2012)

Identification of recurrent 3q13.31 chromosomal rearrangement indicates LSAMP as a tumor suppressor gene in neuroblastoma
por: Martinez-Monleon, Angela, et al.
Publicado: (2023)

Aggressive neuroblastomas have high p110alpha but low p110delta and p55alpha/p50alpha protein levels compared to low stage neuroblastomas
por: Fransson, Susanne, et al.
Publicado: (2013)

Identification of epigenetically regulated genes that predict patient outcome in neuroblastoma
por: Carén, Helena, et al.
Publicado: (2011)

Recurrent inactivation of STAG2 in bladder cancer is not associated with aneuploidy
por: Balbás-Martínez, Cristina, et al.
Publicado: (2013)

Genome-wide methylation profiling identifies novel methylated genes in neuroblastoma tumors
por: Olsson, Maja, et al.
Publicado: (2016)

Whole-genome sequencing of recurrent neuroblastoma reveals somatic mutations that affect key players in cancer progression and telomere maintenance
por: Fransson, Susanne, et al.
Publicado: (2020)

The microenvironment of human neuroblastoma supports the activation of tumor-associated T lymphocytes
por: Carlson, Lena-Maria, et al.
Publicado: (2013)

The loss of DLG2 isoform 7/8, but not isoform 2, is critical in advanced staged neuroblastoma
por: Keane, Simon, et al.
Publicado: (2021)

Genetic and epigenetic changes in the common 1p36 deletion in neuroblastoma tumours
por: Carén, H, et al.
Publicado: (2007)

Verification of genes differentially expressed in neuroblastoma tumours: a study of potential tumour suppressor genes
por: Thorell, Kaisa, et al.
Publicado: (2009)

Quantitative global and gene-specific promoter methylation in relation to biological properties of neuroblastomas
por: Kiss, Nimrod B, et al.
Publicado: (2012)

A genome-wide scan to locate regions associated with familial vesicoureteral reflux
por: Bartik, Zsuzsa, et al.
Publicado: (2022)

Age dependence of tumor genetics in unfavorable neuroblastoma: arrayCGH profiles of 34 consecutive cases, using a Swedish 25-year neuroblastoma cohort for validation
por: Cetinkaya, Cihan, et al.
Publicado: (2013)

Sustained Response to Entrectinib in an Infant With a Germline ALKAL2 Variant and Refractory Metastatic Neuroblastoma With Chromosomal 2p Gain and Anaplastic Lymphoma Kinase and Tropomyosin Receptor Kinase Activation
por: Treis, Diana, et al.
Publicado: (2022)

Amplification of CDK4 and MDM2: a detailed study of a high-risk neuroblastoma subgroup
por: Martinez-Monleon, Angela, et al.
Publicado: (2022)

Comprehensive SNP array study of frequently used neuroblastoma cell lines; copy neutral loss of heterozygosity is common in the cell lines but uncommon in primary tumors
por: Kryh, Hanna, et al.
Publicado: (2011)

High-resolution array copy number analyses for detection of deletion, gain, amplification and copy-neutral LOH in primary neuroblastoma tumors: Four cases of homozygous deletions of the CDKN2A gene
por: Carén, Helena, et al.
Publicado: (2008)

Genetic Instability and Intratumoral Heterogeneity in Neuroblastoma with MYCN Amplification Plus 11q Deletion
por: Villamón, Eva, et al.
Publicado: (2013)

Gain of chromosome arm 17q is associated with unfavourable prognosis in neuroblastoma, but does not involve mutations in the somatostatin receptor 2 (SSTR2) gene at 17q24
por: Abel, F, et al.
Publicado: (1999)

Tumor Development, Growth Characteristics and Spectrum of Genetic Aberrations in the TH-MYCN Mouse Model of Neuroblastoma
por: Rasmuson, Agnes, et al.
Publicado: (2012)

Investigation of the role of SDHB inactivation in sporadic phaeochromocytoma and neuroblastoma
por: Astuti, D, et al.
Publicado: (2004)

Clinical response of the novel activating ALK-I1171T mutation in neuroblastoma to the ALK inhibitor ceritinib
por: Guan, Jikui, et al.
Publicado: (2018)

High Expression of PPM1D Induces Tumors Phenotypically Similar to TP53 Loss-of-Function Mutations in Mice
por: Milosevic, Jelena, et al.
Publicado: (2021)

A cluster of genes located in 1p36 are down-regulated in neuroblastomas with poor prognosis, but not due to CpG island methylation
por: Carén, Helena, et al.
Publicado: (2005)

Cell culture and Drosophila model systems define three classes of anaplastic lymphoma kinase mutations in neuroblastoma
por: Chand, Damini, et al.
Publicado: (2013)

PPM1D Is a Therapeutic Target in Childhood Neural Tumors
por: Milosevic, Jelena, et al.
Publicado: (2021)

Whole exome sequencing identifies KIF26B, LIFR and LAMC1 mutations in familial vesicoureteral reflux
por: Bartik, Zsuzsa I., et al.
Publicado: (2022)

Loss of heterozygosity of 3p markers in neuroblastoma tumours implicate a tumour-suppressor locus distal to the FHIT gene.
por: EjeskÃ¤r, K., et al.
Publicado: (1998)

Different NIPBL requirements of cohesin-STAG1 and cohesin-STAG2
por: Alonso-Gil, Dácil, et al.
Publicado: (2023)

Why Is Aneuploidy Associated with Favorable Outcome in Neuroblastoma?
por: Tonini, Gian Paolo
Publicado: (2021)

Frequent truncating mutations of STAG2 in bladder cancer
por: Solomon, David A., et al.
Publicado: (2013)

STAG2 inactivation reprograms glutamine metabolism of BRAF-mutant thyroid cancer cells
por: Li, Xinru, et al.
Publicado: (2023)

Distinct and overlapping roles of STAG1 and STAG2 in cohesin localization and gene expression in embryonic stem cells
por: Arruda, Nicole L., et al.
Publicado: (2020)

The Genomic Landscape of the Ewing Sarcoma Family of Tumors Reveals Recurrent STAG2 Mutation
por: Brohl, Andrew S., et al.
Publicado: (2014)

STAG1 vulnerabilities for exploiting cohesin synthetic lethality in STAG2-deficient cancers
por: van der Lelij, Petra, et al.
Publicado: (2020)

Planar cell polarity gene expression correlates with tumor cell viability and prognostic outcome in neuroblastoma
por: Dyberg, Cecilia, et al.
Publicado: (2016)

Paralogous synthetic lethality underlies genetic dependencies of the cancer-mutated gene STAG2
por: Bailey, Melanie L, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5s5na7mfukcva42nhhajl3rv1o